Sign In
Buy RGLS
$8.16
+0 (+0%)
At Close: Sep 24, 2025
Regulus Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
04:40pm, Thursday, 09'th Sep 2021
SAN DIEGO, Sept. 9, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs
Regulus Therapeutics' (RGLS) CEO Jay Hagan on Q2 2021 Results - Earnings Call Transcript
09:28pm, Tuesday, 10'th Aug 2021
Regulus Therapeutics' (RGLS) CEO Jay Hagan on Q2 2021 Results - Earnings Call Transcript
Regulus Therapeutics Announces Timing for Second Quarter 2021 Financial Results Webcast and Conference Call
05:15pm, Tuesday, 03'rd Aug 2021
SAN DIEGO, Aug, 3, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (th
3 Popular Penny Stocks For Your August 2021 Watchlist
09:12am, Tuesday, 03'rd Aug 2021
Looking for popular penny stocks to watch? Check these 3 out The post 3 Popular Penny Stocks For Your August 2021 Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
8 Hot Penny Stocks That You Should Add to Your July Watchlist
11:43am, Friday, 02'nd Jul 2021
With July in full swing, here's 8 penny stocks that investors are watching right now The post 8 Hot Penny Stocks That You Should Add to Your July Watchlist appeared first on Penny Stocks to Buy, Picks
Regulus Therapeutics Presents Additional Data From Rare Kidney Disease Program
01:38pm, Friday, 25'th Jun 2021
Regulus Therapeutics Inc (NASDAQ: RGLS) announced the presentation of additional data from the first cohort from Phase 1b trial of RGLS4326 for autosomal dominant polycystic kidney disease (ADPKD),
SAN DIEGO, June 25, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (t
Reddit Penny Stocks to Buy? 7 You Need to Know About In July
02:36pm, Tuesday, 22'nd Jun 2021
Looking for the best penny stocks to watch in July? Check these 7 out for your list The post Reddit Penny Stocks to Buy?
SAN DIEGO, June 21, 2021 /PRNewswire/ -- Regulus Therapeutics Inc . (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (
7 Hot Penny Stocks to Watch That Are Trending Right Now
07:36pm, Sunday, 20'th Jun 2021
Which penny stocks are worth buying next month? Check these 7 out for your watchlist The post 7 Hot Penny Stocks to Watch That Are Trending Right Now appeared first on Penny Stocks to Buy, Picks, News
Biotech Penny Stocks To Watch For June 2021
10:24am, Sunday, 06'th Jun 2021
These penny stocks are expecting to release key information this month. The post Biotech Penny Stocks To Watch For June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS
Regulus Therapeutics Announces Incremental Update of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program
08:07am, Friday, 21'st May 2021
SAN DIEGO, May 21, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (
Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit
04:07pm, Friday, 14'th May 2021
SAN DIEGO, May 14, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (
Regulus Therapeutics Inc. (RGLS) CEO Jay Hagan on Q1 2021 Results - Earnings Call Transcript
09:16pm, Thursday, 13'th May 2021
Regulus Therapeutics Inc. (RGLS) CEO Jay Hagan on Q1 2021 Results - Earnings Call Transcript
Regulus (RGLS) Reports Q1 Loss, Misses Revenue Estimates
06:11pm, Thursday, 13'th May 2021
Regulus (RGLS) delivered earnings and revenue surprises of 11.11% and -100.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
